LOTREKA

Capsule, hard, 75mg
RxActive license

Active substance (INN)

dabigatran etexilate

Pharmaceutical form

Pharmaceutical formCapsule, hard
Strength75mg
PackagingUkupno 60 kapsula tvrdih u blisteru djeljivom na pojedinačne doze (6x(10x1)) u kartonskoj kutiji
ManufacturerStada Arzneimittel AG, Germany
Therapeutic groupBlood and blood forming organs (B01AE07)
Marketing authorization holderHEMOFARM A.D. VRŠAC P.J. PODGORICA
Authorization dateSeptember 2, 2025

Analogs in Montenegro

14

Other medicines with the same active substance

BEREVINRx
Capsule, hard, 150mgGedeon Richter Plc.
BEREVINRx
Capsule, hard, 110mgGedeon Richter Plc.
DABIGATRAN SKRx
Capsule, hard, 110mgTowa Pharmaceutical Europe
DABIGATRAN SKRx
Capsule, hard, 150mgTowa Pharmaceutical Europe
DABIGATRAN SKRx
Capsule, hard, 110mgTowa Pharmaceutical Europe
DABIGATRAN SKRx
Capsule, hard, 75mgTowa Pharmaceutical Europe
DAXANLORx
Capsule, hard, 110mgKrka d.d.
DAXANLORx
Capsule, hard, 150mgKrka d.d.
LOTREKARx
Capsule, hard, 110mgStada Arzneimittel AG
LOTREKARx
Capsule, hard, 150mgStada Arzneimittel AG
PRADAXARx
Capsule, hard, 150mgBoehringer Ingelheim Pharma GmbH & Co. KG
PRADAXARx
Capsule, hard, 110mgBoehringer Ingelheim Pharma GmbH & Co. KG
PRADAXARx
Capsule, hard, 110mgBoehringer Ingelheim Pharma GmbH & Co. KG
PRADAXARx
Capsule, hard, 75mgBoehringer Ingelheim Pharma GmbH & Co. KG
Data obtained from the official medicines registry of the CInMED Agency of Montenegro — cinmed.me ↗
Data updated: April 2026